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Abstract
Background: The former standard surgical treatment in
patients with primary hyperparathyroidism (pHPT)
has been bilateral cervical exploration. New localiza-
tion techniques and the possibility of intraoperative
measurement of intact parathormone (iPTH) permit a
focused, minimally invasive parathyroidectomy (MIP).
The introduction of MIP without complete neck ex-
ploration leads to the potential risk of missing thyroid
pathology. The aim of the present study is to evaluate
the value of MIP in respect to coexisting thyroid find-
ings and their impact on preoperative workup for pri-
mary hyperparathyroidism.
Methods: This is a prospective study including 30 con-
secutive patients with pHPT (median age 65 years; 17
females, 13 males). In all patients preoperative local-
ization was performed by ultrasonography and 99mTc-
MIBI scintigraphy- Intraoperative iPTH monitoring
was routinely done.
Results: Ten patients (33%) had a concurrent thyroid
finding requiring additional thyroid surgery, and two
patients (7%) with negative localization results under-
went bilateral neck exploration. Therefore, MIP was
attempted in 18 (60%) patients. The conversion rate to
a four gland exploration was 6% (1/18). The sensitivi-
ties of 99mTc-MIBI scanning and ultrasonography were
83.3% and 76.6%, respectively. The respective accura-
cy rates were 83.3% and 76.6%. Of note, the combi-
nation of the two modalities did not improve the sen-
sitivity and accuracy in our patient population. During
a median follow-up of 40 months, none of the pa-
tients developed persistent or recurrent hypocal-
caemia, resulting in a 100% cure rate.
Conclusion: Coexisting thyroid pathology is relatively
frequent in patients with pHPT in our region. Among
patients having pHPT without any thyroid pathology,
the adenoma localization is correct with either ultra-
sonography or 99mTc-MIBI scintigraphy in the majori-
ty of cases. MIP with iPTH monitoring are highly suc-
cessful in this group of patients and this operative
technique should be the method of choice.
Key words: Primary Hyperparathyroidism, parathyroid
imaging, parathormone monitoring, surgery, thyroid
pathology
INTRODUCTION
Parathyroidectomy is the accepted curative option for
hyperparathyroidism (HPT). Definite preoperative lo-
calization of parathyroid adenomas and advances in
surgical techniques in combination with intraoperative
measurement of intact parathormone (iPTH) have
made minimally invasive parathyroidectomy (MIP) an
acceptable surgical approach for patients with primary
hyperparathyroidism (pHPT) [1-4]. Therefore, MIP
has become a widely-accepted alternative to the stan-
dard four gland exploration for patients with pHPT.
Over the past ten years, several different approaches
of MIP have been described. These include total en-
doscopic parathyroidectomy, video-assisted tech-
niques, radio-guided explorations and focused para-
thyroidectomy using mini-incisions either by a central
or lateral approach directly over the adenoma [3, 5-8].
All these techniques have considerable advantages and
disadvantages. MIP has been reported to reach suc-
cess rates over 90% and to be associated with a low
complication rate. Common to all MIP procedures is
the abandonment of routine bilateral neck explo-
ration in patients undergoing parathyroidectomy.
These minimal invasive procedures are mostly based
on an unequivocal preoperative localization of
parathyroid adenomas on 99m-Technetium-Methoxy-
isobutylisonitril (99mTc-MIBI) scintigraphy. With MIP
the surgeon may not be able to examine the entire
thyroid gland for associated pathology. The rate of in-
cidentally detected thyroid pathology in patients with
pHPT has been reported to range from 17%-84% [9-
13]. The frequency of malignant thyroid lesions in
population with pHPT ranges from 2% to 12% [9, 11,
14, 15].
To improve the investigative success for most thy-
roid pathologies ultrasonography should be used in
addition to 99mTc-MIBI scan [16-18]. Ultrasound en-
ables to screen the thyroid gland for pathologies while
localizing the parathyroid adenoma at the same time.
However, early diagnosis and simultaneous surgical
treatment especially for thyroid cancer continues to be
a central part of treatment. Delayed diagnosis can re-
sult in more difficulties at the time of second neck ex-
ploration, and in an increased complication rate.
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ue of focused open MIP in respect to coexisting thy-
roid findings and their impact on preoperative workup
for primary hyperparathyroidism.
PATIENTS AND METHODS
From April 2003 to November 2006 a total of 46
parathyroidectomies were performed at our institu-
tion. Sixteen had secondary and tertiary HPT and were
excluded from the study. The study was approved by
the of the Basel University hospital ethical committee
and each patient gave informed consent to participate
the study.
Therefore, 30 patients with pHPT were included in
this prospective, non-randomized study. There were
17 female and 13 male patients with a median age of
65 years (range 34–77). Clinical symptoms were fa-
tigue and depression in 5/30 patients, concurrent hy-
pertension in 14/30, nephrolithiasis in 6/30, bone dis-
ease (elevated alkaline phosphatase) in 16/30, pain in
the extremities in 3/30 and peptic ulcer in 2/30. Five
patients were asymptomatic.
The choice of operative approach was influenced
by the localization results. All patients received preop-
erative 99mTc-MIBI scanning and ultrasonography for
localization of diseased parathyroid. The thyroid was
additionally assessed during ultrasonography.
Exclusion criteria for MIP contained the presence
of concomitant thyroid disease with necessity for sur-
gical treatment, a suspicion of multiglandular disease,
and negative or not conclusive preoperative localiza-
tion. Patients with concomitant thyroid pathology did
not routinely undergo a fine needle aspiration (FNA)
as they unequivocally needed surgery for their hyper-
parathyroidism.
Patients qualifying for MIP received an offer to
choose between local and general anesthesia. The skin
incision was limited to a length of 2.5 cm preferably in
a natural skin crease. A focused MIP was then per-
formed based on preoperative localization results.
Surgery in patients with coexisting thyroid pathology
was always performed under general anesthesia and
exploration was started on the side where pathologies
have been found in imaging studies. In patients with-
out conclusive preoperative localization regarding
parathyroid adenoma the neck exploration was started
on the side of thyroid pathology with the intention to
limit surgery to unilateral exploration.
Since 1990 a commercially available immuno-chemi-
luminometric assay (IMMULITE Turbo intact PTH,
Diagnostic Products Corporation, Los Angeles USA)
was applied for quantification of iPTH. This 15
minute quick assay uses two polyclonal antibodies
against intact PTH, one coated on a polystyrene bead
and another conjugated to alkaline phosphatase. Re-
sults were usually transmitted within 30 minutes by
phone to the operating theatre. PTH levels were moni-
tored at baseline (5 minutes before skin incision), and
10 minutes after parathyroidectomy. An decrease of
iPTH levels of more than 78 % from baseline 10 min-
utes after removal of the parathyroid gland is equiva-
lent to successful resection of enlarged glands [19].
We assessed the serum calcium levels on the first post-
operative day and documented potential surgical and
metabolic complications.
RESULTS
This study includes 30 patients treated for pHPT. Ten
patients (33%) had a concurrent thyroid finding (Table
1) requiring additional thyroid surgery. Four patients
of those with thyroid and parathyroid pathology on
the same side received unilateral exploration. Two pa-
tients (7%) with negative localization results under-
went bilateral neck exploration.
Eighteen patients (60%) met the criteria for open
MIP based on successful localization of a solitary en-
larged gland with 99mTc-MIBI scintigraphy and ultra-
sonography. One out of these 18 got no conclusive re-
sults using this approach. She was additionally studied
using magnetic resonance imaging (MRI) that eventu-
ally revealed a single enlarged parathyroid adenoma
dorsal from the left thyroid lobe.
The sensitivities of 99mTc-MIBI scanning and of ul-
trasonography in this study were 83.3% and 76.6%, re-
spectively (Table 2). As expected the sensitivities of
both localization modalities were higher and lower in
patients without and with thyroid pathology, respec-
tively (Table 3 and 4). Of note, the combination of
the two modalities did not improve the sensitivity in
our patient population. The exact intraoperative loca-
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Table 1. Concomitant thyroid pathology.
Pathology n
Multinodular goiter 4
Uninodular goiter 2
Hashimoto thyroiditis 1
Thyroid adenoma 1
Oncocytic neoplasia 1
Papillary thyroid carcinoma pT3,pN1(2/20), G2 1
Total 10
Table 2. Reliability of Sesta-MIBI and Ultrsonography for Location of Parathyroid Adenomas.
Modality n True positive False positive True negative False negative Sensitivity Specificity Accuracy
(%) (%) (%)
Sestamibi 30 25 005 83.3 - 83.3
Ultrasound 30 22 007 76.6 - 76.6
Combined 30 25 005 83.3 - 83.3
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than predicted by 99mTc-MIBI scan and by ultrasound,
respectively. This results in a gland-specific (exact
anatomic location) accuracy rate of 83.3% and 76.6%,
respectively. One patient without conclusive preopera-
tive localization had two glands removed. Histological
examination revealed a double adenoma situation and
a rate of multiglandular disease rate of 3%.
MIP was successfully carried out in 17/18 patients
(94%). Because of an ectopically located (para-
esophageal) right upper gland, which has originally
been attributed to a right lower parathyroid by imag-
ing, one patient (1/18) needed conversion to the con-
ventional unilateral approach (i.e. a conversion rate of
6%). Three patients opted for MIP under local anes-
thesia, which was successfully carried out in all three
cases.
The median preoperative levels for serum calcium
and PTH was 2.89 mmol/l (range 2.71–3.7 mmol/l;
normal values are 2.10–2.65 mmol/l) and 250 pg/ml
(range 102 - 1892 pg/ml; normal values 10-73 pg/ml),
respectively.
During the initial postoperative course twenty-six
patients were normocalcaemic, four were subclinical
hypocalcaemic and one patient (after conventional
four gland exploration) developed hoarseness due to
transient recurrent laryngeal nerve palsy. This resolved
within two weeks postoperatively. Therefore no per-
manent postoperative complication occurred. The me-
dian postoperative PTH level (10 minutes after adeno-
ma removal) was 33pg/ml (range, 17–80pg/ml). The
median postoperative calcium level 24 hours postoper-
atively was 2.24mmol/l (range, 1.94 –2.59mmol/l).
All 17 patients after MIP procedure and 9 patients
after conventional four gland exploration (26 out of
30) were discharged 24 hours postoperatively, whereas
the remaining four patients with hypocalcaemia need-
ed longer observation and were discharged 48 hours
after surgery.
Calcium levels at least 1 month after surgery were
available in all 30 patients (100%) at a median follow-
up time of 40 (range 21-63) months. During follow-up
evaluation no patient developed persistent or recurrent
hyperparathyroidism. Histological examination of all
removed glands was confirmed benign parathyroid tis-
sue changes. Thus, with the use of iPTH monitoring,
MIP and conventional neck exploration resulted in a
100% success rate.
DISCUSSION
Today, minimally invasive, targeted parathyroidectomy
has achieved wide acceptance among endocrine sur-
geons. The present investigation provides evidence
that MIP is feasible in about two thirds of patients
with pHPT in an endemic goiter region. However, the
33 % proportion of patients with additional thyroid
findings is quite high. Nevertheless, a 100% cure rate
could be achieved by the selective use of MIP com-
bined with the conventional neck exploration for pa-
tients who were not suitable for MIP at our institu-
tion.
Surgery is the accepted curative option for sympto-
matic and asymptomatic hyperparathyroidism, respec-
tively. The introduction and refinement of parathyroid
imaging was a pre-condition for the development of
MIP techniques. Several non-invasive preoperative lo-
calization methods are available, including 99mTc-MIBI
scintigraphy, ultrasonography, CT, MRI and thallium-
technetium-pertechnetate subtraction scanning. Today,
the most common procedures for preoperative local-
ization are 99mTc-MIBI scintigraphy and ultrasonogra-
phy. A meta-analysis of sensitivity and specificity of
99mTc-MIBI scanning provided rates of 90,7% and
98,8%, respectively, and suggested that more than
80% of the patients with pHPT would be candidates
for MIP [20]. Of note, these data originate from re-
gions where goitrous changes are not endemic. In our
institution, situated in a region where goiter is endem-
ic, 33% of patients presented with additional thyroid
pathologies. Still, this leaves two thirds of patients be-
ing eligible for MIP.
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Table 3. Reliability of Sesta-MIBI and Ultrsonography for Location of Parathyroid Adenomas with concomitant Thyroid
Pathology.
Modality n True positive False positive True negative False negative Sensitivity Specificity Accuracy
(%) (%) (%)
Sestamibi 12 8004 66.6 - 66.6
Ultrasound 12 7005 58.3 - 58.3
Combined 12 8004 66.6 - 66.6
Table 4. Reliability of Sesta-MIBI and Ultrsonography for Location of Parathyroid Adenomas without concomitant Thyroid
Pathology.
Modality n True positive False positive True negative False negative Sensitivity Specificity Accuracy
(%) (%) (%)
Sestamibi 18 17 00 1 94.4 - 94.4
Ultrasound 18 16 00 2 88.8 - 88.8
Combined 18 17 00 1 94.4 - 94.4
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perfunctional parathyroid tissue in the neck and in the
mediastinum as well. With ultrasound only the neck
region can reliably be scanned. A major limitation of
99mTc-MIBI scans is, however, related to multiglandu-
lar parathyroid disease [21] and to the concomitant
thyroid pathology that can mimic parathyroid adeno-
mas resulting in false-positive results. The results of
present study are also supporting this influence of co-
existing thyroid pathology on preoperative work up.
This limitation can be managed by combining Sesta-
MIBI scanning with neck ultrasound which usually
distinguishes between thyroid nodules and enlarged
parathyroid glands [22, 23]. The ultrasonography is ef-
fective, inexpensive and shows true-positive rates ap-
proaching 90% when combined with 99mTc-MIBI [24].
CT and MRI both provide cross-sectional imaging that
can occasionally be useful for localization of enlarged
parathyroid glands that are ectopically situated
retropharyngeal and retroesophageal within the neck
and the mediastinum as shown in this study. CT is less
expensive, and many studies have shown that these
two techniques have an equal sensitivity. The innova-
tive SPECT /CT modality enables the combined scan-
ning with image fusion resulting in a more precise
anatomic localization of the tracer activity.
The high success of MIP has been confirmed by
evidence of cure without complications in our study
that are at least as good as those achieved by conven-
tional bilateral neck exploration [3, 25, 26]. The poten-
tial advantages of MIP include the possible use of lo-
cal anesthesia, reduced operating times of up to 50%,
a lower incidence of hypocalcaemia, reduction of hos-
pital stay and reduction by nearly one half in total hos-
pital charges [3]. In line with this, in the present study
no hypocalcaemia was noted in patients undergoing
MIP. Furthermore, after MIP all patients were dis-
charged 24 hours postoperatively. Based on these ben-
efits we currently prefer MIP as described by Udels-
man et al. [27].
The rapid PTH assay for intraoperative hormone
monitoring has an integral role in the intraoperative
decision process during MIP. According to most as-
says, a 50% reduction in the quick iPTH value from
the baseline level is used as an indication that surgery
has been successful and this is predictive of cure in
96% of cases [28]. Based on a recently published
prospective validation study we advocate an iPTH de-
crease to below 22% from the baseline level at 10 min-
utes after parathyroidectomy to be most accurate for
complete removal of all hyperplastic parathyroid tissue
[19]. We are convinced that such a stringent decrease
of iPTH is imperative to distinguish between single-
and multiglandular disease. With a 50% reduction rate
at 10 minutes only, as formerly proposed by Irvin [29],
we could potentially have missed multiglandular dis-
ease.
In conclusion, coexisting thyroid findings are rela-
tively frequent in patients with pHPT and substantially
influence the preoperative workup in our region. Ul-
trasonography helped identifying concomitant thyroid
pathologies in a large subset of our patient popula-
tion. We therefore recommend the routine use of ul-
trasonography in combination with 99mTc-MIBI scinti-
graphy in regions where goiter is endemic. However,
among patients having pHPT without any thyroid
pathology, the adenoma localization is correct with ei-
ther ultrasonography or 99mTc-MIBI scintigraphy in
the majority of cases. MIP with iPTH monitoring and
is highly successful in this group of patients and the
operative technique is regarded to be the method of
choice. The imperative condition for a successful MIP
is an accurate preoperative localization test (i.e. 99mTc-
MIBI) combined with the evaluation for coexisting
thyroid abnormalities (i.e. cervical ultrasound), partic-
ularly with respect to one-stage surgery for both
pathologies.
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